Premarket Movers Sept 24, 2026: APUS, SRZN, PFSA
APUS soars 190% on a reverse stock split, SRZN surges 79% in a high-conviction short squeeze, and PFSA, WETO, and NCPL are all jumping before the open on September 24, 2026.
APUS — Apimeds Pharmaceuticals US (+190.3%)
Apimeds Pharmaceuticals US is up a staggering 190.3% in premarket trading, changing hands at $6.59 on 20,810,432 shares — more than 128 times its 20-day average volume of 162,279. That kind of volume dislocation in a name with a $3.4 million market cap demands immediate context.
Why it's moving: The company completed a 1-for-10 reverse stock split effective September 23, 2026, as confirmed by an 8-K filed with the SEC that same day and widely reported across financial news outlets. In a reverse split, a company consolidates existing shares — here, every 10 shares become 1 — which mechanically multiplies the share price by 10. That accounting move is the primary driver of the headline percentage gain; it is not a fundamental improvement in the business.
It's important to understand what a reverse split is and isn't: it does not change the total value of a shareholder's position (10 shares at $0.65 become 1 share at $6.50, all else equal), and companies often execute them to avoid exchange delisting rules tied to minimum share prices. With APUS sitting 93.5% below its 52-week high, a conviction score of just 4/100, a D technical grade, and an RSI of only 38, the prior-day chart shows a deeply beaten-down stock with no bullish trend structure. The MA stack remains bearish, and the ADX of 18 signals a weak trend environment.
Short interest is negligible (19,919 shares, 0.1 days to cover), so a squeeze is not in play here. The three-outside-up candle pattern on the prior daily chart could suggest a short-term reversal attempt, but given the reverse-split context, extreme caution is warranted. Reverse-split stocks frequently see sharp post-split volatility that fades quickly.
SRZN — Surrozen, Inc. (+78.8%)
Surrozen is surging 78.8% to $29.00 premarket on volume of 2,608,457 shares — roughly 14 times its 20-day average of 185,337. This is a $190.6 million market-cap biotech with a very different story from APUS.
Why it's moving: No specific catalyst headline is on file ahead of the open. With no confirmed news, the move appears to be technically and squeeze-driven. Surrozen carries a squeeze score of 81/100 — one of the most compelling short-squeeze setups in this morning's scan. To understand why that matters: a short squeeze happens when traders who have bet against a stock (short sellers) are forced to buy shares to cover their losing positions, which in turn pushes the price higher and forces even more covering — a self-reinforcing cycle.
The data supports squeeze dynamics here. Short interest stands at 1,445,491 shares with 7.7 days to cover — meaning at average volume, it would take short sellers more than a week to fully unwind their positions. Short volume is 65% of recent activity. The free float (the portion of shares actually available to trade) is just 47.9%, which tightens supply and amplifies price moves when demand spikes. The largest disclosed stake is 9.9%, further concentrating the available float.
The prior-day chart shows a stock well off its 52-week high (down 52.5%) with a bearish MA stack, an RSI of 27 (deeply oversold), and an ADX of 31 (a meaningful trend in force — in this case, a downtrend). An oversold, heavily shorted, low-float stock with no lane signal is a classic setup for a violent snap-back. The smart-money score is 24/100, and the prior gap was a modest -1.0%. Traders should note that the most intense squeeze moves can reverse just as fast once covering pressure exhausts itself.
PFSA — Profusa, Inc. (+71.2%)
Profusa is jumping 71.2% to $3.51 in premarket trading on 38,670,116 shares — nearly 64 times its 20-day average of 600,377. The company has a market cap of just $1.2 million, making it one of the most micro-cap names on this morning's board. A short-sale restriction (SSR) is already active, meaning regulators have restricted certain types of short-selling after yesterday's decline — a rule that kicks in when a stock falls more than 10% from the prior close.
Why it's moving: No specific catalyst headline accompanies the move this morning. The stock filed multiple 8-Ks over recent weeks — covering an agreement (September 16), another agreement (September 1), a vote (September 21), and notably a delisting-related 8-K on August 31 — but none of these filings have a confirmed bullish trigger tied to today's move. With no clear catalyst, this looks like a momentum and volume-driven surge in a thinly traded micro-cap.
The technical picture from yesterday's close is telling: PFSA sits 99.6% below its 52-week high — essentially a stock that has lost nearly all of its value over the past year. The MA stack is bearish, RSI is 46 (neutral), and the ADX of 35 suggests a trending environment. An inverted hammer candlestick on the prior daily chart hints at a potential reversal attempt, but in this context it's a fragile signal. A 13D/G filing indicates a disclosed activist or large-stake holder (the largest stake is 49.9%), and HRT Financial LP made a series of small insider purchases between August and September, though those buys were modest in dollar terms. The conviction score is 24/100 and the grade is D.
With essentially zero days to cover (short interest is only 39,618 shares), a squeeze is not the story. This is a lottery-ticket-style move in an ultra-micro-cap with serious fundamental headwinds. The active SSR does limit some short-side pressure intraday, but that's a double-edged dynamic in a name this small.
WETO — Wetour Robotics Ltd (+35.4%)
Wetour Robotics is up 35.4% to $1.99 premarket on 14,937,292 shares — about 2.2 times its already-elevated 20-day average of 6,842,356. The $120.5 million market-cap robotics company, which files as a foreign private issuer (6-K filings), is one of the more liquid names on this morning's list and has a short-sale restriction (SSR) active.
Why it's moving: A Benzinga report dated September 24 — this morning — notes that WETO stock "rallies over 59% after hours" and is trending, though the specific catalyst cited in that headline is not detailed in the data on file. That after-hours surge is what is rolling into today's premarket reading of +35.4% versus the prior close. Traders should note that the after-hours and premarket percentage figures may differ as prices continue to move before the open.
The prior-day chart reveals a stock with almost no technical support: WETO is 99.1% below its 52-week high, has a conviction score of 0/100, a D grade, a bearish MA stack, an RSI of 35, and an ADX of just 10 (a directionless, range-bound environment). The trend-template score is 0 — the weakest possible reading. The free float is 25.9%, and short interest is negligible (35,047 shares, 0.0 days to cover), so squeeze dynamics are not a meaningful factor. An August 424B5 filing — a follow-on share offering — is a bearish structural signal, as it dilutes existing shareholders.
This is a highly speculative, momentum-driven move in a name that has shed nearly all of its value over the past year. Without a confirmed fundamental catalyst, the move is difficult to evaluate with conviction.
NCPL — Netcapital Inc. (+35.2%)
Netcapital is rising 35.2% to $1.46 premarket on 10,205,385 shares. Interestingly, that volume is actually below its 20-day average of 31,686,655 — meaning this is a name that routinely sees heavy retail activity, and today's premarket move is happening on comparatively lighter participation. The $8.5 million market-cap fintech is the only name on this morning's list with a meaningful positive technical profile.
Why it's moving: No catalyst headline is on file for this morning's move. The stock appeared in a light Reddit mention on r/pennystocks (rank #124, 1 mention), and recent SEC filings include two management-related 8-Ks and a delisting-related 8-K from August 28 — a lingering risk worth noting. With no confirmed news, the move reads as technically and momentum-driven.
What separates NCPL from the other names this morning is its technical rank of 99/100 — placing it in the top 1% of all stocks StockSetups scans for technical setup quality — along with an RS rating of 94 (strong relative strength versus the broader market), a conviction score of 53/100, a grade of C, and a trend-template score of 4. The prior-day chart shows a mixed MA stack, an RSI of 71 (approaching overbought territory), an ADX of 39 (a strong trend in force), and a prior-day gap up of 8.3%. This is the only stock in today's premarket lineup showing genuine momentum and trend characteristics rather than a distressed bounce.
The squeeze score is 43/100 with 1,651,407 shares short and 0.0 days to cover, so a mechanical squeeze isn't the primary driver. Still, with above-average short volume (45%) and a rising RSI, any continuation catalyst could bring in fast-money buyers quickly. The delisting 8-K from August remains an overhang, and the stock is 57.5% below its 52-week high — so the broader trend is still one of recovery from a significant drawdown.
The bottom line
This morning's biggest premarket gainers span a wide range of dynamics: a reverse-split accounting move (APUS), a high-conviction short squeeze in a heavily shorted biotech (SRZN), a momentum surge in an ultra-micro-cap (PFSA), an after-hours catalyst rollover in a foreign robotics name (WETO), and technically-driven strength in a fintech with genuine momentum (NCPL).
A few honest reminders before the open:
- Reverse-split stocks (APUS) can look explosive in percentage terms but the move is largely mechanical — the underlying business hasn't changed.
- Short squeezes (SRZN) can be violent and fast in both directions; once covering pressure exhausts itself, the reversal can be just as sharp.
- Micro- and nano-cap names (PFSA, WETO) with no confirmed catalyst and bearish fundamental signals carry extreme risk of rapid reversals once early buyers take profits.
- Chasing stocks that are already up 35–190% before the open is high-risk. Premarket prices are set on thin volume and often do not hold after the 9:30 AM ET open.
- Nothing here is a buy recommendation. These are educational observations for traders doing their own research.
StockSetups scans the full ~12,300-stock US universe every premarket morning — flagging unusual volume, short-squeeze setups, pattern confirmations, and smart-money signals before the open. For yesterday's after-close recap, see Top Stock Movers Sept 23, 2026: BENF, WHLR, VSA. To learn how gap moves like these play out in the regular session, the Gap-and-Go Setup guide and the VWAP Fade Setup are worth reading before the open. Manage your risk, size accordingly, and do your own research.
Frequently asked questions
Why is APUS stock up today?
Apimeds Pharmaceuticals (APUS) is up over 190% premarket after completing a 1-for-10 reverse stock split effective September 23, 2026. The reverse split mechanically multiplied the share price by 10 but did not change the underlying value of shareholders' positions or improve the company's fundamentals.
Why is SRZN stock up today?
Surrozen (SRZN) is surging nearly 79% premarket with no confirmed catalyst on file. The move appears squeeze-driven: SRZN has a squeeze score of 81/100, short interest of 1.4 million shares, 7.7 days to cover, and a free float of just 47.9% — classic conditions for a short squeeze, where short sellers are forced to buy back shares, pushing the price higher.
What is a short squeeze and why does it matter for premarket movers?
A short squeeze happens when traders who have bet against a stock (short sellers) are forced to buy shares to close losing positions as the price rises. This buying pressure pushes prices even higher, forcing more covering in a self-reinforcing loop. Stocks with high short interest, few days to cover, and a small float — like SRZN this morning — are most vulnerable to squeezes.
Why is PFSA stock up today?
Profusa (PFSA) is up 71% premarket on volume roughly 64 times its average, but no specific catalyst headline is confirmed for this morning's move. The surge appears momentum-driven in an ultra-micro-cap ($1.2M market cap) that is 99.6% below its 52-week high, making it highly speculative.
What does a short-sale restriction (SSR) mean for WETO and PFSA?
A short-sale restriction (SSR) is activated by regulators when a stock falls more than 10% from its prior close. While SSR is active, certain types of short-selling are restricted, which can reduce downside pressure intraday. Both WETO and PFSA have SSR active this morning, but SSR alone does not guarantee continued upside.
Produced with AI assistance and published under the StockSetups editorial guidelines.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →